Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2002
08/22/2002WO2002064832A1 Method of examining allergic disease
08/22/2002WO2002064831A2 Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis
08/22/2002WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002WO2002064820A1 Dna markers for meat tenderness
08/22/2002WO2002064814A2 Expression of human milk proteins in transgenic plants
08/22/2002WO2002064802A2 Regulatory genes suitable for use in gene expression
08/22/2002WO2002064799A2 Optimized messenger rna
08/22/2002WO2002064798A1 Dna sequences differentially expressed in tumour cell lines
08/22/2002WO2002064794A2 Herbicide target genes and methods
08/22/2002WO2002064793A2 G protein-coupled receptor-like proteins and nucleics acids encoding same
08/22/2002WO2002064792A2 Molecules for disease detection and treatment
08/22/2002WO2002064791A2 Proteins and nucleic acids encoding same
08/22/2002WO2002064790A2 Jfy1 protein induces rapid apoptosis
08/22/2002WO2002064789A1 Protein-coupled receptor
08/22/2002WO2002064788A2 Compositions and methods relating to lung specific genes and proteins
08/22/2002WO2002064787A1 Neurotonin and use thereof
08/22/2002WO2002064786A1 Novel gene tcif
08/22/2002WO2002064785A1 NOVEL CLOCK GENE Bmal2
08/22/2002WO2002064784A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
08/22/2002WO2002064783A2 Novel cofactors of the estrogen receptor beta and methods of use
08/22/2002WO2002064782A2 Rank ligand-binding polypeptides
08/22/2002WO2002064781A2 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
08/22/2002WO2002064780A1 Dna sequences for human tumour suppressor genes
08/22/2002WO2002064779A2 Peptide inhibitors of cellular proliferation
08/22/2002WO2002064777A2 Proteins 7b6 and 11b4 and dna sequences encoding the same
08/22/2002WO2002064776A2 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences
08/22/2002WO2002064775A1 Identification of genes involved in the tumourigenic process
08/22/2002WO2002064772A1 Human nmda receptor splice variant
08/22/2002WO2002064771A1 Novel cell adhesion molecule specific to activated leukocyte
08/22/2002WO2002064770A1 Novel scavenger receptor class a protein
08/22/2002WO2002064769A1 Novel disease marker
08/22/2002WO2002064768A1 Method of screening inhibitor for the chromosomal segregation function of bacterium and inhibitor obtained by the screening method
08/22/2002WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi
08/22/2002WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities
08/22/2002WO2002064750A2 Expression system for seed proteins
08/22/2002WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002WO2002064747A2 Fusion proteins based upon somatostatin receptors
08/22/2002WO2002064744A2 Compositions and methods relating to colon specific genes and proteins
08/22/2002WO2002064742A2 Compounds effecting neuron remodeling and assays for same
08/22/2002WO2002064741A2 Compositions and methods relating to breast specific genes and proteins
08/22/2002WO2002064740A2 Cone snail peptides
08/22/2002WO2002064739A2 A cytokine related structurally to il-17
08/22/2002WO2002064736A2 Protein-protein interactions
08/22/2002WO2002064734A2 Identification of target-specific folding sites in peptides and proteins
08/22/2002WO2002064733A2 Protein-protein interactions
08/22/2002WO2002064732A2 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF
08/22/2002WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/22/2002WO2002064632A2 Crystallized ppar$g(a) ligand binding domain polypeptide and screening methods employing same
08/22/2002WO2002064631A2 T1r taste receptors and genes encoding same
08/22/2002WO2002064630A2 Il-1 receptor accessory protein
08/22/2002WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
08/22/2002WO2002064628A2 Isolated human transporter proteins nucleic acids and use thereof
08/22/2002WO2002064627A2 Crystallization of igf-1
08/22/2002WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/22/2002WO2002064625A1 Matrix gene expression in chondrogenesis
08/22/2002WO2002064622A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
08/22/2002WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002WO2002064620A2 Metal-binding compounds and uses therefor
08/22/2002WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
08/22/2002WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10
08/22/2002WO2002064611A1 Compositions and methods relating to breast specific genes and proteins
08/22/2002WO2002064556A2 Complex carbohydrate arrays and methods for the manufacture and uses thereof
08/22/2002WO2002064165A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
08/22/2002WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen
08/22/2002WO2002064159A1 Remedies for tumor in hematopoietic organs
08/22/2002WO2002064154A2 Methods and compositions for inhibiting hiv-coreceptor interactions
08/22/2002WO2002064097A2 Vegf-d expression in brain cancer
08/22/2002WO2002064092A2 Method for evaluating therapeutic efficacy
08/22/2002WO2002064091A2 Melanocortin metallopeptides for treatment of sexual dysfunction
08/22/2002WO2002064025A2 Inhibition of atf2 activity to treat cancer
08/22/2002WO2002064023A2 Fra-1 expression in brain cancer
08/22/2002WO2002064021A2 Methods and compositions for control of bone formation via modulation of ciliary neurotrophic factor activity
08/22/2002WO2002063975A2 Feed additive compositions and methods
08/22/2002WO2002063959A1 Methods and compositions for stimulating axon regeneration and prventing neuronal cell degeneration
08/22/2002WO2002053583A3 Amphipathic peptides and their use for transferring substances of interest into cells
08/22/2002WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/22/2002WO2002043658A3 Fcrn-based therapeutics for the treatment of auto-immune disorders
08/22/2002WO2002028999A3 Gene expression profiles in granulocytic cells
08/22/2002WO2002026107A3 Model for neurodegenerative diseases involving amyloid accumulation
08/22/2002WO2002015939A3 Calycins
08/22/2002WO2002010394A3 Nucleic acids, by means of which plants with altered metabolite content can be produced
08/22/2002WO2002008250A3 Ghrelin antagonists
08/22/2002WO2002004486A3 Bi-functional fusion proteins from hirudin and tap
08/22/2002WO2002002602A3 Slgp protein and nucleic acid molecules and uses therefor
08/22/2002WO2002000689A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR11, AND USES THEREOF
08/22/2002WO2002000001A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF
08/22/2002WO2001092330A3 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
08/22/2002WO2001088090A3 Cng3b: a novel cyclic nucleotide-gated cation channel
08/22/2002WO2001087958A3 CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
08/22/2002WO2001083737A3 Porcine adenovirus type 5 vector and vaccine
08/22/2002WO2001083553A3 G protein-coupled receptors
08/22/2002WO2001079477A3 Identification, isolation and use of a wheat storage protein gene variant
08/22/2002WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof
08/22/2002WO2001072775A3 Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
08/22/2002WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/22/2002WO2001070982A3 Brca-1 regulators and methods of use
08/22/2002WO2001068887A3 Hypoallergenic transgenic soybeans
08/22/2002WO2001042506A9 T1 receptor-like ligand ii and uses thereof
08/22/2002WO2001008720A3 Hypocretin and hypocretin receptors in regulation of sleep and related disorders
08/22/2002WO2000038706A9 Methods for treating cancer and for mediating chemotaxis of dendritic cells